Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

$Citius Pharmaceuticals (CTXR.US)$ Let's analyze it for ever...

$Citius Pharmaceuticals (CTXR.US)$ Let's analyze it for everyone, if this bullish news can skyrocket before the market opens tonight, it proves that it still has hope.
1. Tomorrow, the merger will eliminate delisting risks.
The exercise price of the institution is 0.25, which will be converted to 6.25 tomorrow. Although diluting shares is annoying, it also provides an additional insurance for the current stock price.
3. A pharmaceutical is about to start selling.
4, two pharmaceuticals are making smooth progress with the FDA.
So personally, I think the current stock price is already very safe (NFA).
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
3
+0
2
See Original
Report
599 Views
Comment
Sign in to post a comment
103Followers
5Following
726Visitors
Follow